Specialist small- and micro-cap Australian equities investment manager NAOS Asset Management has taken its philosophy into the private markets, with the launch of its Private Opportunities Fund, for which it is seeking to raise at least $35 million. The fund will invest in up to 20 private companies that NAOS identifies as being profitable, having…
The resources exploration-project development end of the Australian Securities Exchange (ASX) is an exciting place to spend time; one really gets a sense of how the share market kicked-off in Australia in the 1850s, when no boomtime goldfield town was complete without its own stock exchange. It is, potentially, the home of the multi-bagger –…
An essential part of developing a drug is the requirement for tests on human volunteers, usually starting in Phase 1. But for Noxopharm’s Veyonda drug, the first human volunteer was the company’s CEO and managing director, Dr. Graham Kelly. It was 2014, and some of the top cancer specialists in Australia had told Kelly that…
Sydney-based drug developer Pharmaxis (ASX:PXS) is moving through a pivot that the market is taking its time to understand, as it takes its lead drug candidate PXSâ€5505 firstly through a Phase 1/2a trial for the treatment of the rare bone marrow cancer myelofibrosis, and secondly, into pre-clinical efficacy testing for glioblastoma (GBM), the most common form…
If you want to find gold, one of the best theories to go on is to look where it’s been found before – and that’s what Theta Gold Mines Limited (ASX: TGM) has done. Theta’s core project is located in the Eastern Transvaal Gold Fields of South Africa, where that country’s gold mining industry began…
Plenty of companies assert that “innovation” is their guiding principle, but Melbourne-based Hydrix Limited takes it more literally than most. Four years ago, when it arrived on the ASX through a merger with the listed Panorama Synergy, Hydrix was a product engineering consultancy that designed and developed prototypes for clients from around the world, from…
ASX investors are very well-used to the SaaS, or “software as a service” business model, under which customers pay to use software hosted on a remote computer – in the “cloud” – rather than buying a software licence and installing it on their physical computers. Under the SaaS model, customers subscribe to a software product…
So, Fortescue Metals Group (ASX: FMG) shareholders have learned that their company is to become a hydrogen and steel superpower. Andrew Forrest, the founder, non-executive chairman and largest shareholder of Fortescue, says Fortescue will lead the way in building a steel-making industry in Australia, making “green” steel – zero-carbon steel, using zero carbon-dioxide-emissions energy. There…
Macquarie Investment Management is now a bigger manager than AMP Capital – and the outlook for the respective stocks appears to reflect that ranking. Macquarie Investment Management has taken AMP Capital’s crown as the largest Australian-owned manager of Australian assets, moving to $125.7 billion in assets in the year to September 2020, according to the…
With interest rates at all-time lows, and term deposits lucky to be paying 0.5%, investors have simply been forced to look for alternative income-generating investments. The share market has obliged, but not only in the form of normal equity dividends – but in newer listed income-bearing investments. One of the most recent offerings came last…
